Show simple item record

dc.contributor.authorRebolj, Matejka
dc.contributor.authorParmar, Dharmishta
dc.contributor.authorMaroni, Roberta
dc.contributor.authorBlyuss, Oleg
dc.contributor.authorDuffy, Stephen W
dc.date.accessioned2020-02-05T01:09:40Z
dc.date.available2020-02-05T01:09:40Z
dc.date.issued2019-09-16
dc.identifier.citationRebolj , M , Parmar , D , Maroni , R , Blyuss , O & Duffy , S W 2019 , ' Concurrent participation in screening for cervical, breast, and bowel cancer in England ' , Journal of Medical Screening , pp. 1-9 . https://doi.org/10.1177/0969141319871977
dc.identifier.issn0969-1413
dc.identifier.otherPURE: 18773158
dc.identifier.otherPURE UUID: 444b9874-010f-458e-9ade-2f353918865c
dc.identifier.otherPubMed: 31525303
dc.identifier.otherScopus: 85073986502
dc.identifier.otherORCID: /0000-0002-0194-6389/work/69424494
dc.identifier.urihttp://hdl.handle.net/2299/22156
dc.description.abstractObjectives: To determine how many women participate in all three recommended cancer screening programmes (breast, cervical, and bowel). During their early 60s, English women receive an invitation from all the three programmes. Methods: For 3060 women aged 60–65 included in an England-wide breast screening case–control study, we investigated the number of screening programmes they participated in during the last invitation round. Additionally, using the Fingertips database curated by Public Health England, we explored area-level correlations between participation in the three cancer screening programmes and various population characteristics for all 7014 English general practices with complete data. Results: Of the 3060 women, 1086 (35%) participated in all three programmes, 1142 (37%) in two, 526 (17%) in one, and 306 (10%) in none. Participation in all three did not appear to be a random event (p < 0.001). General practices from areas with less deprivation, with more patients who are carers or have chronic illnesses themselves, and with more patients satisfied with the provided service were significantly more likely to attain high coverage rates in all programmes. Conclusions: Only a minority of English women is concurrently protected through all recommended cancer screening programmes. Future studies should consider why most women participate in some but not all recommended screening.en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofJournal of Medical Screening
dc.subjectBreast cancer
dc.subjectbowel cancer
dc.subjectcervical cancer
dc.subjectparticipation
dc.subjectscreening
dc.subjectHealth Policy
dc.subjectPublic Health, Environmental and Occupational Health
dc.titleConcurrent participation in screening for cervical, breast, and bowel cancer in Englanden
dc.contributor.institutionSchool of Physics, Astronomy and Mathematics
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85073986502&partnerID=8YFLogxK
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.1177/0969141319871977
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record